Looking for BMS2052 - Microbes in health and disease - S2 2025 test answers and solutions? Browse our comprehensive collection of verified answers for BMS2052 - Microbes in health and disease - S2 2025 at learning.monash.edu.
Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!
Q17. The doctor initiates antibiotic therapy with polymyxin while awaiting antibiotic susceptibility testing results for the causative bacterium. Explain why polymyxin is not a suitable antibiotic therapy in this situation. (2-3 sentences) (2 marks)
Q11. How will an excess of IgM (but a lack of IgG and IgA) affect Terry’s humoral immune response to extracellular bacteria? (2-3 sentences) (2 marks)
Q10. Explain how a defect in CD40L leads to the Hyper-IgM phenotype. (2-3 sentences) (2 marks)
Q16. The causative bacterium also secretes hyaluronidase. Explain how this enzyme likely contributes to bacterial pathogenesis and the formation of abscesses. (1-2 sentences) (2 marks)
Q14. Further testing confirms that the causative bacterium is catalase positive, and a positive test result was observed when a BactiStaph test was performed. What is the most likely identity of the causative bacterium?
Q13. Doctors suspect that the causative bacterium is part of Terry’s normal skin microbiota that entered the body via a small cut on his knee, leading to abscess formation. How would you classify this infection? (select all that apply)
Q15. The causative bacterium secretes a toxin which forms pores in host cell membranes and causes cell lysis. Secretion of this toxin contributes to the tissue damage observed in Terry’s abscess. How would you classify this toxin?
Q8. What type of antibody response would you aim to elicit through vaccination, and how would this response protect against RhoV? (2-3 sentences) (2 marks)
Q5. RhoV has been associated with increased rates of lung carcinoma in individuals with long-term infection. Explain how RhoV infection could contribute to oncogenesis. (2-3 sentences) (2 marks)
Q9. What type of T-cell response would you aim to elicit through vaccination, and how would this response be protective against RhoV infection? (2-3 sentences) (2 marks)